Article
Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).
Current protocols in pharmacology - 22 Jun 2017
Dunbar Andrew, Nazir Abbas, Levine Ross
Abstract excerpt
Myeloproliferative neoplasms (MPNs) are a class of hematologic diseases characterized by aberrant proliferation of one or more myeloid lineages and progressive bone marrow fibrosis. In 2005, seminal work by multiple groups identified the JAK2V617F mutation in a significant fraction of MPN patients. Since that time, murine models of JAK2V617F have greatly enhanced the understanding of the role of aberrant JAK-STAT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
